Utilising both the Ang II-infusion and elastase-infusion models, enhancing circulating miR-29 levels augmented AAA growth [101], whereas miR-29 inhibition limited AAA expansion [89,101]. The gene discussed is AGT; the disease is triple-A syndrome.